Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo

Lysosomal cysteine peptidase cathepsin B, involved in multiple processes associated with tumor progression, is validated as a target for anti-cancer therapy. Nitroxoline, a known antimicrobial agent, is a potent and selective inhibitor of cathepsin B, hence reducing tumor progression in vitro and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitrović, Ana, Sosič, Izidor, Kos, Špela, Tratar, Urša Lampreht, Breznik, Barbara, Kranjc, Simona, Mirković, Bojana, Gobec, Stanislav, Lah, Tamara, Serša, Gregor, Kos, Janko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601720/
https://www.ncbi.nlm.nih.gov/pubmed/28938624
http://dx.doi.org/10.18632/oncotarget.19296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601720/
https://www.ncbi.nlm.nih.gov/pubmed/28938624
http://dx.doi.org/10.18632/oncotarget.19296

Ejemplares similares